Back to UBS Group AG UBS Group AG

ATRAATRA
9 quarters

Position history for UBS Group AGUBS Group AG's holdings in ATARA BIOTHERAPEUTICS INC

UBS Group AG holds 3,979 shares of ATRA (ATARA BIOTHERAPEUTICS INC), worth $45,679 as of 2026-Q2. The position was decreased (-92.0% shares).

Current Value

$45,679

Current Shares

3,979

Total Value Change

+$42,253

Total Shares Change

+3,576

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,979
-92.0%
$45,6790.0%$11.48
0
2026-Q1
Increased
50,070
+3484.1%
$236,8310.0%$5.42
25
2025-Q4
Decreased
1,397
-91.9%
$25,2710.0%$17.88
0
2025-Q3
Increased
17,268
+105.9%
$247,4510.0%$13.81
25
2025-Q2
Decreased
8,385
-65.5%
$64,7320.0%$7.96
0
2025-Q1
Increased
24,334
+2817.8%
$144,5440.0%$6.53
25
2024-Q4
Increased
834
+107.5%
$11,1010.0%$13.28
19
2024-Q3
Decreased
402
-0.3%
$3,2680.0%$8.07
0
2024-Q2
New
403
-
$3,4260.0%$8.50
21

Other major holders of ATRA: ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., VANGUARD GROUP INC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used